InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by Cross Shawn, Chief Financial Officer. Director active across 1 companies, notably Applied Molecular Transport Inc.. Aggregated, 7 filings have been published. Total volume traded: €5k. The latest transaction was disclosed on 1 June 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€4,9221,767 shares@ €2.785767.5% of flow
Common Stock
SEC:0001209191-22-034352:0·
018,000 shares0
Common Stock
SEC:0001209191-22-030208:0·
020,250 shares0
Common Stock
SEC:0001209191-22-010366:0·
031,500 shares0
Common Stock
SEC:0001209191-22-002244·
031,500 shares0
Common Stock
SEC:0001209191-22-002244:0·
€1,184300 shares@ €3.9481100.0% of flow
Common Stock
SEC:0001209191-21-053042·
€1,184300 shares@ €3.948116.2% of flow
Common Stock
SEC:0001209191-21-053042:0·
7 of 7 declarations
About Cross Shawn
Shawn Cross is the Chief Financial Officer and President & COO of Applied Molecular Transport Inc., a company specializing in developing innovative therapies. In his role, he oversees financial operations and contributes to the company's growth strategy. Shawn Cross plays a crucial role in managing financial resources and optimizing Applied Molecular Transport's economic performance.
